A new paradigm

for cardiac monitoring

The need

Accurate + Predictive + Non-Invasive

Mission critical cardiac monitoring for critical care, operating rooms and heart failure patients has historically required invasive pulmonary catheters and implants. We aim to change that.

The platform

Next Generation Capabilities

Our approach combines a unique physiological signal, off-the-shelf sensors, and cloud computing to predict patient health.

The results

Game Changing Potential

Our early clinical studies show that Respirix can already predict 87% of the signal in an implant that is the standard of care for heart failure monitoring.

Team

Eric Kriegstein

CEO

Daniel Burnett

Chairman & Co-Founder

Michael Jaasma

CSO

Bryan Nowroozi

Data Science

Alex Vergara

Engineering

Carin Lindquist

Clinical

Advisors

Michael Lesh

MD

Riccardo Turchetto

Geoffrey Tison

MD, MPH

Paul L. Marino

MD, PhD

Support From

Contact us